Error loading player: No playable sources found
3285
Intestinal Inflammation, Fibrosis, and Regeneration
Date
May 19, 2024
SOCIETY: AGA
Moderators
University of California Davis
Cleveland Clinic Foundation
Tracks
Related Products
Gut Microbiome — Ally or Foe for Immune Checkpoint Inhibitors
SOCIETY: AGA This session will explore the complex dynamics between the gut microbiome and immune checkpoint inhibitors, addressing whether specific microbes/metabolites enhance therapeutic outcomes acting as allies or present challenges as potential foes, impacting treatment efficacy and associate…
Irritable Bowel Syndrome in Inflammatory Bowel Disease: Boundaries Along a Continuum
SOCIETY: AGA IBS-like symptoms in patients with IBD are common, yet presenting a diagnostic and clinical challenge for patients and their providers…
AGA Beyond Gut Bacteria: Transkingdom Interactions Underlying GI Diseases
Through the history of gut microbiome research, basic, translational, and clinical studies revealed many critical roles played by gut-resident bacteria in affecting human health and disease…
